©ñ¤j¹Ï¤ù
±ç¦ë
¡@§Y¨Ïªñ´X©uÁÚ§JªºSingulair¡B½÷·çªºLipitor¡BÁÉ¿Õµá/Bristol-MyersªºPlavix¡B§¨Ó¤½¥qªºZyprexa¡BForest LaboratoriesªºLexaproµ¥²£«~´Áº¡¡AÅý¼t°Ó±¹ï³à¥¢150»õ¤¸(¬ü¤¸¡A¤U¦P) ªº±M§Q²£«~Äa±V¡FµM¦Ó§Y¨Ï¬ÛÃöªº«D±M§QÃĽÄÀ»¡A¦ý¼t°Ó¬ãµo²£«~³z©ú¤Æ¥H¤Î·sÃĶ}©lªºÅãµÛ·~ÁZ°^Äm¡A¨Ï±o¼Ð´¶¯S¿ï¤u·~ªO¶ô«ü¼Æ¤¤ªº¥Í¬ì·~ªO¶ô¤µ¦~²Öpªº36.9%º¦´T¡A¦¨¬°²Ä¤G¨Îªº¼Ð´¶¤u·~ªO¶ô¡C³oªO¶ô¤µ¦~ªí²{¥X¦â¡A¦ý¼¥¼©¨äÀu¶ÕÁÙ·|±a°Ê«á¥«ªí²{§ó¤W¼h¼Ó¡A¤£§«¦ø¾÷¦¬¶°«ØÜ¡C
¡@¾Ú°òª÷¸g²zªí¥Ü¡A¥þ²y°ªÄÖ¤H¤f¼W¥[¡A¢¨Ï¦U°ê¬F©²§ë¤JÂåÀø·ÓÅU¸ê·½¤£Â_¤W¤É¥~¡A·s¿³¥«³õ¦]ªì¯ÅÂåÀø«O°·³]¬Iªº§ïµ½¡B°¾»·¦a°ÏÂåÀø¥i¤Î©Êªº´£°ª¡A»PÓ¤HÂåÀø«OÀI³vº¥´¶¤Î¤Æ¡A¨Ï±o±M§QÃÄ©M·s¬ãµoÃĪ«±NÀò±o¥«³õÂX®iªº¾÷¹J¡A³£¬O¤ä¼µªO¶ôµo®iªº«GÂI¡C
¡@¥H´IÄõ§JªLªº¥Íª«¬ì§Þ·s»â°ì°òª÷¬°¨Ò¡A¥Dn¬O³z¹L¦b¬ü°êªº¥Íª«§Þ³N²£·~Ãì¤W¥«¤½¥qªºªÑ²¼ºÞ²z²Õ¦X¡C
¡@°òª÷¦b2009¡B2010©M2011¦~ªí²{¤À§O¬°10.86%¡B17.63%¤Î9.6%¡C°òª÷¥§¡¥«¬Õ²v©M¼Ð·Ç®t¬°19.92¿¤Î16.88%¡C¸ê²£¦Ê¤À¤ñ¬°94.34% ªÑ²¼¤Î5.66% ³f¹ô¥«³õ¡C
¡@¸ê²£¦a°Ï¤À¥¬¬°94.79% ¬ü°ê¡B3.56% ^°ê¡B0.96% ·Rº¸Äõ¡B0.32% ¥[®³¤j¤Î0.37% ·N¤j§Q¡C°òª÷¤T¤j¸ê²£¤ñ«ªÑ²¼¬°9.3% ¦N§Q¼w¬ì¾Ç¡B7.19% Celgene¤Î7.02% Amgen¡C
¡@¦¹¥~¡A¥t¤@¤ä¼µªO¶ôµo®iªº«GÂI¬O¨ÖÁʶÕÀY¤£´î¡A¤µ¦~¥Dnªº¥æ©ö´N¦³±j¥Í¨ÖÁÊSynthes¡BBristol-Myers Squibbs¨ÖÁÊAmylin¡B¸¯Äõ¯À¥v§J¨ÖÁÊ Human Genome Sciences¡A Valeant Pharma¤]§Y±N¦¬ÁÊMedicis¡C
¤¤«á´Á·sÃÄÁ{§É·m¦û¥ý¾÷
¡@«D±M§QÃĤ豴N¦³Teva¨ÖÁÊCephalon©MµØ¥Í»sÃĨÖÁÊActavis¡F¦b¥_¬ü¥H¥~¡AÁÉ¿Õµá¨ÖÁÊGenzyme¡A´N´£¤É¤F«eªÌªº¦¬¤J¤Î±À°Ê¨ä¬ãµo²£«~ºÞ¹D¡A¥H¤Îªü´µ§Q±d¨ÖÁÊArdea Biosciencesµ¥¡C»P´Á±qµL¨ì¦³ªº°_¨B¥h¶}µo·s²£«~¡A¯A¤Î¨ì¤j¶qªº¸êª÷©M®É¶¡¦¨¥»¡Aˤ£¦pª«¦â¦³¤¤´Á¦Ü«á´Á¶¥¬q²£«~¬ãµoºÞ¹DԿ綠¥q¡A¸`¬Ù®É¶¡¦¨¥»¤§¾l¡A¤]¬°¥¼¨ÓµoªíÁ{§É¹êÅç¼Æ¾Ú´£¨Ñ¼¥¼©¡A¦Ó·sÃÄÁ{§É¼Æ¾Úªí²{¨Î¡A¤]¥[§ÖÃÄ«~³\¥iÃÒ§å®Ö¡A¬°¤½¥q·m¦û¥«³õ¥ý¾÷¡C
|